How much does Gefitinib cost per month through medical insurance?

Gefitinib (Gefitinib) is a drug used to treat non-small cell lung cancer (NSCLC), especially for patients with epidermal growth factor receptor (EGFR) mutations. Drug prices may vary across regions and hospitals, and health insurance policies may also change over time.

Gefitinib was launched in China in 2005. At that time, the price of a box was about 5,000 yuan. Enter medical insurance in China in 2017. The price after medical insurance has dropped a lot. For the specific price after medical insurance, please consult the local hospital pharmacy or the medical insurance bureau. Other versions include original drugs and cost-effective generic drugs. Generic drugs include generic drugs from India, Bangladesh and Laos. The prices vary with different specifications, about 200~800yuan, and the ingredients of generic drugs are basically the same as domestic drugs.

In China, drug prices are usually affected by multiple factors, including pharmaceutical manufacturers' pricing, drug production costs, market supply and demand, and government health insurance policies. Drug prices can fluctuate as these factors change.

Normally, gefitinib is included in the drug list of local medical insurance, and patients can enjoy medical insurance reimbursement when purchasing it. Health insurance policies may cover part or all of the drug costs, thereby easing the financial burden on patients.

For the most accurate and up-to-date information, it is recommended that you consult a medical institution, pharmacy or health insurance department in your area. They can provide you with information about gefitinib drug prices, insurance reimbursement rates, and costs. Please note that because drug prices and policies may change, it is important to ensure you have the most up-to-date information to make accurate decisions.